Clay Capital

Clay Capital, formerly known as VisVires New Protein, is a Singapore-based venture capital firm focused on agrifood technology. In 2023, the firm closed its second fund at $145 million, signaling a strong commitment to transforming the food and agriculture sectors. Clay Capital backs innovative startups across Europe, Asia, and Israel that are working to create sustainable and regenerative food systems. Its investment strategy targets technologies that address key issues like food security, sustainability, and environmental health. With initial investments ranging from $3 million to $8 million, Clay Capital supports startups working on solutions in areas such as regenerative agriculture, crop disease resistance, and sustainable packaging. The firm’s portfolio includes companies like Toopi Organics, which repurposes human urine as a bio-stimulant, and In Ovo, which develops sex determination technologies to reduce the culling of male chicks in the poultry industry. Clay Capital’s approach emphasizes connecting the Asian and European markets, leveraging its expertise and network to help startups expand globally. This cross-continental strategy reflects the firm’s vision of creating a healthier and more sustainable food system while fostering innovation in agrifood tech.